Plasma homocysteine level is elevated in patients on isotretinoin therapy for cystic acne: A prospective controlled study

Journal of Dermatological Treatment

Volumn 19, Issue 4, 2008, Pages 229-232

  Polat, Muhterem ^a,c   Lenk, Nurdan ^a   Bingöl, Sezin ^a   Öztaş, Pinar ^a   Ilhan, Mustafa N ^b   Artüz, Ferda ^a   Alli, Nuran ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c NONE   (Turkey)

Author keywords

Cystic acne; Homocysteine; Isotretinoin

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; ISOTRETINOIN;

ACNE CYSTICA; ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIDE EFFECT; STUDENT T TEST;

ACNE VULGARIS; ADOLESCENT; ADULT; DERMATOLOGIC AGENTS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; ISOTRETINOIN; LIVER FUNCTION TESTS; MALE; PROSPECTIVE STUDIES; VITAMIN B 12; YOUNG ADULT;

EID: 48249113271     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630701846079     Document Type: Article

References (32)

1. Saurat JH. Oral isotretinoin. Where now, where next. Dermatology. 1997;195(suppl 1):1-3.
2. Goulden V, Layton AM, Cunliffe W. Long-term safety of isotretinoin as a treatment for acne vulgaris. Br J Dermatol. 1994;131:360-3.
3. Mills C, Marks R. Adverse reactions to oral retinoids. Drug Saf. 1993;9:280-9.
4. Roenick HR. Liver toxicity in retinoid therapy. J Am Acad Dermatol. 1988;19:199-206.
5. Taylor AEM, Michinson H. Fatty liver following isotretinoin therapy. Br J Dermatol. 1991;124:505-10.
6. Schulpis KH, Georgala S, Papakonstantinou ED, Karikas GA. The effect of isotretinoin on biotinidase activity. Skin Pharmacol. 1999;12:28-33.
7. Malinow MR, Kang SS, Taylor LM, Wong PW. Prevalence in hyperhomocysteinemia in patients with peripheral arterial occlusive disease. Circulation. 1989;79:1180-8.
8. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RC, Alvarez JO, et al. Plasma homocysteine, folate and vitamin B12 concentrations and risk of early-onset coronary artery disease. Am J Clin Nutr. 1994;59:940-8.
9. Quinlivan EP, McPartlin J, McNulty H, Ward M, Strain JJ, Weir DG, et al. Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet. 2002;359:227-8.
10. Schynder G, Roffi M, Flammer Y, Pin R, Hess OM. Homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention. The Swiss Heart Study: A randomized controlled trial. JAMA. 2002;288:973-9.
11. Schulpis KH, Karikas GA, Georgala S, Michas T, Tsakiris S. Elevated plasma homocysteine levels in patients on isotretinoin therapy for cystic acne. Int J Dermatol. 2001;40:33-6.
12. Verhoef P, Kok FJ, Kruyssen DA, Schouten EG, Witteman JC, Grobbee, et al. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 1997;17:989-95.
13. Langman LJ, Ray JG, Evrovski J, Yeo E, Cole DE. Hyperhomocysteinemia and the increased risk of venous thromboembolism: More evidence from a case-control study. Arch Intern Med. 2000;160:961-4.
14. Tanne D, Haim M, Goldbourt U, Boyko V, Dolman R, Adler Y, et al. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke. 2003;34:632-6.
15. Kang SS, Wong PW, Malinow MR. Hyperhomocysteinemia as a risk factor for occlusive vascular disease. Annu Rev Nutr. 1992;12:279-98.
16. Chu RC, Hall CA. The total serum homocysteine as an indicator of vitamin B12 and folate status. Am J Clin Pathol. 1988;90:446-449.
17. Kang SS, Wong PWK, Norusis M. Homocysteinemia due to folate deficiency. Metabolism. 1987;36:458-62.
18. Stabler SP, Marcell PD, Podell ER, Allen RH, Savage DG, Lindenbaum J. Elevation of total homocysteinemia in the serum of patients with cobalamine or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest. 1988;81:466-74.
19. Gisondi P, Fantuzzi F, Malerba M, Girolomoni G. Folic acid in general medicine and dermatology. J Dermatolog Treat. 2007;18:138-46.
20. Sombolos K, Papaioannou A, Christidou F, Natse T, Bamichas G, Gionanlis L, et al. The effect of two different doses comprising the simultaneous administration of intravenous B-complex vitamins and oral folic acid on serum homocysteine levels in hemodialysis patients. Int Urol Nephrol. 2006;38:725-30.
21. Homocysteine Lowering Trialists' Collaboration, Dose-dependent effects of folic acid on blood concentrations of homocysteine: A meta-analysis of the randomized trials. Am J Clin Nutr. 2005;82:806-12.
22. Lee BJ, Huang MC, Chung LJ, Cheng CH, Lin KL, Su KH, et al. Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease. Eur J Clin Nutr. 2004;58:481-7.
23. Earnest CP, Wood KA, Church TS. Complex multivitamin supplementation improves homocysteine and resistance to LDL-C oxidation. J Am Coll Nutr. 2003;22:400-7.
24. Earnest C, Cooper KH, Marks A, Mitchell TL. Efficacy of a complex multivitamin supplement. Nutrition. 2002;18:738-42.
25. Clarke R, Armitage J. Vitamin supplements and cardiovascular risk: Review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost. 2000;26:341-8.
26. Woodside JV, Yarnell JW, McMaster D, Young IS, Harmon DL, McCrum EE, et al. Effect of B-group vitamins on hyperhomocysteinemia: A double-blind, randomized, factorial-design, controlled trial. Am J Clin Nutr. 1998;67:858-66.
27. Happle R, van de Kerkhof PC, Traupe H. Retinoids in disorders of keratinization: Their use in adults. Dermatologica. 1987;175:107-24.
28. Katuqampola RP, Finlay AY. Oral retinoid therapy for disorders of keratinization: Single-center retrospective 25 years' experience on 23 patients. Br J Dermatol. 2006;154:267-76.
29. Kellum RE. Papillon-Lefevre syndrome in four siblings treated with etretinate. A nine-year evaluation. Int J Dermatol. 1989;28:605-8.
30. Moshell AN. Prevention of skin cancer in xeroderma pigmentosum with oral isotretinoin. Cutis. 1989;43:485-90.
31. De Graaf YG, Euvrard S, Bouwes Bavinck JN. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol Surg. 2004;30:656-61.
32. Lebwohl M, Tannis C, Carrasco D. Acitretin suppression of squamous cell carcinoma: Case report and literature review. J Dermatolog Treat. 2003;14:3-6.